Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcturus Therapeutics Ltd.

12.89
+0.24001.90%
Post-market: 12.890.00000.00%19:34 EDT
Volume:340.93K
Turnover:4.32M
Market Cap:349.57M
PE:-4.30
High:12.94
Open:12.58
Low:12.11
Close:12.65
Loading ...

Arcturus Therapeutics Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Mar

Arcturus Therapeutics Shares Down About 7% at $14.86 After the Bell Following Results

THOMSON REUTERS
·
07 Mar

Arcturus Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
07 Mar

Arcturus Therapeutics Q4 2024 GAAP EPS $(1.11) Misses $(0.44) Estimate, Sales $22.800M Miss $44.650M Estimate

Benzinga
·
07 Mar

BRIEF-Arcturus Therapeutics Q4 Collaboration Revenue USD 21 Million

Reuters
·
07 Mar

Arcturus Therapeutics Q4 Net Income USD -30.005 Million VS. Ibes Estimate USD -15 Million

THOMSON REUTERS
·
07 Mar

Arcturus Therapeutics Holdings Inc -Qtrly Shr Loss $1.11

THOMSON REUTERS
·
07 Mar

Arcturus Therapeutics Q4 Collaboration Revenue USD 21 Million

THOMSON REUTERS
·
07 Mar

Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

Business Wire
·
06 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Mar

Arcturus Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 6, 2025

Business Wire
·
25 Feb

High Growth Tech Stocks In The United States To Watch

Simply Wall St.
·
18 Feb

Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Feb

Arcturus Therapeutics Says EU Commission Approves COVID-19 Vaccine Kostaive

MT Newswires Live
·
14 Feb

European Commission Approves CSL and Arcturus Therapeutics' Kostaive®, the First Self-Amplifying Mrna Covid-19 Vaccine

THOMSON REUTERS
·
14 Feb

European Commission Approves CSL and Arcturus Therapeutics’ Kostaive®, the First Self-Amplifying Mrna Covid-19 Vaccine

THOMSON REUTERS
·
14 Feb

Axsome (AXSM) Surges 20.2%: Is This an Indication of Further Gains?

Zacks
·
11 Feb

Arcturus Therapeutics Appoints Moncef Slaoui Chair Designate

MT Newswires Live
·
04 Feb

Arcturus Therapeutics appoints Moncef Slaoui as chair designate

TIPRANKS
·
04 Feb

Arcturus Therapeutics Announces Appointment of Moncef Slaoui, Ph.d., as Chair Designate

THOMSON REUTERS
·
04 Feb